PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | C0011570|depression |
| Sentences | 34 |
| PubMedID- 22326842 | depression and anxiety in patients with hepatitis c virus (hcv) infection influence their health-related quality of life and their adherence to antiviral treatment. |
| PubMedID- 24608155 | Interferon-alpha induced depression in a patient with hepatitis c. |
| PubMedID- 24644496 | Conclusion: there is a high prevalence of depression among patients with hepatitis b and hepatitis c infection, especially patients on interferon therapy. |
| PubMedID- 22075738 | Objective: to prospectively evaluate depressive symptoms and risk factors for depression in patients with chronic hepatitis c (chc) treated with pegylated interferon alpha therapy combined with oral ribavirin (peg-ifn-alpha+rbv) and to analyze self-rating scale for depression in comparison to observer-based scale in the given population. |
| PubMedID- 21615916 | For instance, ido activity (measured indirectly by the kyn/trp ratio) and an increased neurotoxic potential predict the occurrence of depression in patients with hepatitis c being treated with ifn-α based immunotherapy . |
| PubMedID- 21762832 | Screening for depression in patients with hepatitis c using the beck depression inventory-ii: do somatic symptoms compromise validity. |
| PubMedID- 24204676 | Can antidepressants prevent pegylated interferon-alpha/ribavirin-associated depression in patients with chronic hepatitis c: meta-analysis of randomized, double-blind, placebo-controlled trials. |
| PubMedID- 24934987 | depression was not associated with hepatitis c (hcv-infected 29%, non-infected 35%; p = 0.25). |
| PubMedID- 23942342 | A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis c infection. |
| PubMedID- 20569656 | The prevalence of depression is increased in patients with chronic hepatitis c virus (hcv) infection. |
| PubMedID- 21423320 | Not only is the prevalence of depression in patients with hepatitis c higher than the general population, antiviral therapy increases the likelihood of a variety of neuropsychiatric complications, including worsening depression, anxiety, and suicidal ideation . |
| PubMedID- 21654873 | Risk factors for the development of depression in patients with hepatitis c taking interferon-alpha. |
| PubMedID- 21691274 | Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-alpha-induced depression in patients with chronic hepatitis c. |
| PubMedID- 24608038 | Asymmetric dimethylarginine responses during interferon-alpha-induced depression in patients with chronic hepatitis c infection. |
| PubMedID- 25359924 | Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis c. |
| PubMedID- 24372654 | Objective: to conduct a systematic review and meta-analysis evaluating the efficacy and safety of antidepressant medications for the prevention of interferon-alpha (inf-alpha)-associated depression in patients with chronic hepatitis c virus (hcv). |
| PubMedID- 25663386 | There was a significantly higher rate of depression in patients with hepatitis than in healthy participants (p = 0.003). |
| PubMedID- 23108508 | The role of attachment style and depression in patients with hepatitis c. |
| PubMedID- 24778869 | Although the interaction between fatigue and depression in patients with chronic hepatitis c infection (hcv) has been recognized, the biological correlates of this observation have yet to be reported. |
| PubMedID- 24955454 | Conclusions: a history of depression is common with hepatitis c but does not affect initiation of antiviral treatment, despite substantially increased risk of psychiatric side-effects. |
| PubMedID- 25868672 | We prospectively evaluate depressive symptoms and risk factors for major depression in patients with hepatitis c virus treated with antiviral combined therapy. |
| PubMedID- 26446640 | The risk of external-cause mortality, especially suicide, may be associated with antiviral treatment, as interferon-α treatment has been shown to be associated with increased risk of suicide or major depression in patients with hepatitis,36 and most trials report a 10% to 40% incidence of major depression during antiviral therapy.37 hepatitis b virus infection is highly prevalent in asia and africa, and nationwide vaccination strategies have been adopted to eliminate hepatitis b virus infection in korea. |
| PubMedID- 23058145 | Severity of depression in hepatitis b and hepatitis c patients. |
| PubMedID- 25670957 | Bupropion for interferon-alpha-induced depression in patients with hepatitis c viral infection: an open-label study. |
| PubMedID- 24012293 | Conclusion: antidepressant pretreatment with selective serotonin reuptake inhibitors lowers the incidence and severity of ifn-associated depression in patients with chronic hepatitis c infection or malignant melanoma. |
| PubMedID- 24834219 | depression in patients with chronic hepatitis b: an experience on individual solution- focused therapy. |
| PubMedID- 20587769 | Novel treatment strategies for depression in patients with hepatitis c. |
| PubMedID- 23139898 | Gene expression profiles associated with depression in patients with chronic hepatitis c (ch-c). |
| PubMedID- 24839091 | Serotonin-norepinephrine reuptake inhibitor desvenlafaxine for the treatment of interferon alfa-associated depression in patients with hepatitis c. |
| PubMedID- 23648373 | Specific serotonin reuptake inhibitors prevent interferon-alpha-induced depression in patients with hepatitis c: a meta-analysis. |
| PubMedID- 25116763 | Incidence of depression in patients with chronic hepatitis c receiving combination therapy of pegylated interferon-alpha and ribavirin. |
| PubMedID- 22070000 | Objective: the aim of the study was to identify the presence of depression in patients with chronic hepatitis c, predicting factors for its expression, and the impact of depression on the quality of life in these patients. |
| PubMedID- 24742598 | depression and neuroticism in patients with chronic hepatitis c: correlation with peripheral blood mononuclear cells activation. |
| PubMedID- 24918850 | Interferon-induced depression in patients with hepatitis c: an epidemiologic study. |
Page: 1